Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Kebomed Sverige AB
AB
Active
Org 5569658924
Kanalvägen 6, 194 61
Upplands Väsby
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2014
10 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Kebomed Sverige AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
14M
28M
42M
56M
33M
2021
35M
2022
36M
2023
43M
2024
49M
2025
EBITDA
SEK millions
0M
1M
2M
3M
3M
3M
2021
0M
2022
-1M
2023
2M
2024
1M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
32 912
35 020
36 241
42 865
49 478
Staff expenses
—
—
−8 102
−9 093
−9 588
EBITDA
2 699
452
−688
1 506
629
Depreciation & amort.
−0
−0
—
—
−14
EBIT
2 699
452
−688
1 506
615
Net financials
−165
−480
−593
349
854
Profit before tax
2 534
−28
−1 281
1 855
1 469
Tax
−322
−17
—
−189
−344
Net profit
2 212
−45
−1 281
1 666
1 125
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
14 737
11 322
16 733
17 790
30 321
Equity
6 485
6 440
5 159
6 825
7 951
Long-term debt
0
0
—
—
—
Short-term debt
8 252
4 882
11 574
10 965
22 371
Total debt
8 252
4 882
11 574
10 965
22 371
Financial ratios
5-year trend
EBITDA margin
1.3%
This company
15.8%
Market median
-92% vs market
2021
2025
Equity ratio
26.2%
This company
38.2%
Market median
-31% vs market
2021
2025
Return on equity
14.2%
This company
18.4%
Market median
+23% vs market
2021
2025
Net profit margin
2.3%
This company
8.1%
Market median
-72% vs market
2021
2025
Asset turnover
1.63×
This company
1.12×
Market median
+46% vs market
2021
2025
Debt / equity
2.81×
This company
0.62×
Market median
-353% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
View
PDF
More on Kebomed Sverige AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
